Gerlem Manso Morin, ARNP

Gerlem Manso Morin practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Gerlem Manso Morin's NPI, 1518456565, was assigned on May 4, 2018. Gerlem Manso Morin holds Florida license APRN9308666.

Gerlem Manso Morin's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Gerlem Manso Morin's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. The medical group on file is Baptist Health Medical Group Oncology. Dmand AI also links Gerlem Manso Morin to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gerlem Manso Morin practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Gerlem Manso Morin's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Gerlem Manso Morin is licensed in Florida.

CMS data shows 35 Medicare services from Gerlem Manso Morin across 1 procedure code in 2024, all of them office visits, for 16 Medicare patients. Medicare paid $2,046 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 16 Medicare patients who saw Gerlem Manso Morin in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 5.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gerlem Manso Morin's median patient age at 66, with 0% women.

In 2024, Gerlem Manso Morin wrote 91 Medicare Part D claims for 31 patients. 74% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $76 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Gerlem Manso Morin for performance year 2024, reported as part of a group. Gerlem Manso Morin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 33 general payments to Gerlem Manso Morin from 13 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 87% of the total. Janssen Pharmaceuticals, Inc paid the most, $645.